Breath‑Dx benchmark advances disease screening via time‑series classification with eNose
benchmarks
| Source: HF Papers | Original article
A new benchmark, Breath‑Dx, evaluates time‑series classification methods for disease screening using portable eNose breath analysis, addressing sensor drift challenges.
A new open benchmark called **Breath‑Dx** has been released to standardise machine‑learning research on electronic‑nose (eNose) disease screening. The benchmark, described in an arXiv pre‑print (2611.15348) and accompanied by the S‑OH dataset on Hugging Face, provides a large, clinically sourced collection of 1,234 breath recordings and a suite of ten baseline model families. Crucially, the evaluation protocol uses realistic temporal splits that expose models to sensor drift – a well‑known but rarely quantified failure mode in eNose systems.
The authors show that, under these conditions, sensor drift consistently degrades classification accuracy, while recurrent neural networks retain the most stable performance across a range of diseases. By making the data, code and evaluation scripts publicly available on GitHub, Breath‑Dx aims to replace the fragmented, small‑scale studies that have dominated the field and to give researchers a common yardstick for comparing algorithms.
The benchmark matters because eNose technology promises portable, non‑invasive diagnostics that could complement or even replace traditional lab tests for conditions detectable in exhaled breath. Without a reliable way to assess how models cope with drift over time, progress has been slow and commercial translation uncertain. A shared, rigorous testbed can accelerate the development of robust models, attract investment, and inform standards bodies that are beginning to consider breath‑based diagnostics.
What to watch next is how quickly the community adopts Breath‑Dx. Early uptake will be visible in follow‑up papers that benchmark new architectures against the baseline families, and in competitions or leaderboards that surface top‑performing approaches. In the longer term, successful models that demonstrate drift‑resilient performance could move into clinical trials, paving the way for real‑world eNose devices in hospitals and primary‑care settings across the Nordics and beyond.
Sources
Back to AIPULSEN